" I think the main reason for the delays is the curveball the FDA threw when they asked for vision as a primary endpoint........."
I am surprised ,with all the expertise the company has , that this endpoint was not considered.
It should not have been a "curveball"
A strategy ought to have been in place for this possible outcome .
Read the part on FDA from 23 July 2020 IXC announcement ( a year ago)
Ann: Appendix 4E and Annual Report, page-69
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 17/09/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable